OMNISCAN (GE Healthcare Inc.)


Welcome to the PulseAid listing for the OMNISCAN drug offered from GE Healthcare Inc.. This Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GE Healthcare Inc.
NON-PROPRIETARY NAME: gadodiamide
SUBSTANCE NAME: GADODIAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2002-04-19
END MARKETING DATE: 0000-00-00


OMNISCAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOMNISCAN from GE Healthcare Inc.
LABELER NAME: GE Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 287(mg/mL)
START MARKETING DATE: 2002-04-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0407-0690_39df0de4-7294-4155-8c97-5ab64b384613
PRODUCT NDC: 0407-0690
APPLICATION NUMBER: NDA020123

Other GADODIAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GE Healthcare Inc.OMNISCAN